Arcus Biosciences (RCUS) Enterprise Value: 2017-2025
Historic Enterprise Value for Arcus Biosciences (RCUS) over the last 9 years, with Sep 2025 value amounting to $616.5 million.
- Arcus Biosciences' Enterprise Value rose 99.55% to $616.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.3 billion, marking a year-over-year increase of 5.99%. This contributed to the annual value of $384.6 million for FY2024, which is 42.66% down from last year.
- Per Arcus Biosciences' latest filing, its Enterprise Value stood at $616.5 million for Q3 2025, which was up 1,355.65% from -$49.1 million recorded in Q2 2025.
- Over the past 5 years, Arcus Biosciences' Enterprise Value peaked at $2.3 billion during Q4 2021, and registered a low of -$166.1 million during Q1 2025.
- Over the past 3 years, Arcus Biosciences' median Enterprise Value value was $416.2 million (recorded in 2024), while the average stood at $397.6 million.
- Per our database at Business Quant, Arcus Biosciences' Enterprise Value skyrocketed by 495.30% in 2021 and then slumped by 123.06% in 2025.
- Over the past 5 years, Arcus Biosciences' Enterprise Value (Quarterly) stood at $2.3 billion in 2021, then crashed by 79.16% to $488.4 million in 2022, then skyrocketed by 37.34% to $670.7 million in 2023, then plummeted by 42.66% to $384.6 million in 2024, then soared by 99.55% to $616.5 million in 2025.
- Its Enterprise Value was $616.5 million in Q3 2025, compared to -$49.1 million in Q2 2025 and -$166.1 million in Q1 2025.